2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Joshua Roth, PhD, assistant member, Fred Hutchinson Cancer Research Center, discusses the design of a novel risk-prediction algorithm in the context of screening patients for lung cancer.
Joshua Roth, PhD, assistant member, Fred Hutchinson Cancer Research Center, discusses the design of a novel risk-prediction algorithm in the context of screening patients for lung cancer.
The database analysis used SEER data, which provided detailed information regarding patients with early stage non-small cell lung cancer (NSCLC). Looking at different factors, researchers investigated the likelihood of death within 30 days of surgery.
This data was then fed back to the screening process and can be a part of the conversation between the patient and physician as they discuss treatment options, explains Roth.
Related Content: